mRNA Cancer Vaccine Keeps 70% Melanoma-Free After 5 Years

A groundbreaking study shows personalized mRNA vaccines combined with immunotherapy kept nearly 70% of melanoma patients cancer-free after five years, compared to just 49% with immunotherapy alone.

The same technology that powered COVID-19 vaccines is now transforming how we fight cancer.